Rivaroxaban has less risk of brain bleeding in patients at high risk for stroke

For patients with a type of irregular heart beat called atrial fibrillation (AF), a new anti-clotting drug might be better at preventing clot-related strokes while minimizing the risk of causing a bleeding stroke. The research was presented at the American Stroke Association's International Stroke Conference 2012.

Read the whole article on Physorg

More from Physorg